| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.026 | 0.9 |